SpliceBio Appoints Don Munoz as Chief Financial Officer

BARCELONA--(BUSINESS WIRE)--SpliceBio, a clinical-stage genetic medicines company pioneering protein splicing to address diseases caused by mutations in large genes, today announced the appointment of Don Munoz as Chief Financial Officer. Mr. Munoz, who is based in Boston, is a seasoned biotechnology finance leader with deep experience in financial strategy, operations and corporate development, complemented by a strong background in healthcare investment banking. “As we advance our lead progra